SHBG and metabolic dysfunction-associated steatotic liver disease: SHBG levels are independently associated with the risk of diabetes, dementia, non-alcoholic fatty liver disease, hypertension, coronary heart disease, and ischemic stroke [11–14], all of which are associated with a higher risk of MetS.